Produktname:Diosmetin
IUPAC Name:5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one
| Packungseinheit | Verfügbarer Vorrat | Preis($) | Menge |
|---|---|---|---|
| CM162549-10g | in stock | ǠǠ |
|
| CM162549-25g | in stock | ƩƩƅ |
|
| CM162549-100g | in stock | ȋœǠ |
|
|
|||
| Product Overview |
Diosmetin is a flavonoid compound found in various plants, including citrus fruits, and is known to possess significant biological activities. It is a natural compound with a wide range of potential therapeutic applications. |
| Synthesis and Application |
Diosmetin can be synthesized in a variety of ways, including chemical synthesis, biotransformation, and enzymatic methods. Chemical synthesis involves the reaction of diosmetin with other compounds to form a desired product. Biotransformation is a process in which a compound is converted from one form to another using bacteria or other microorganisms. Enzymatic methods involve the use of enzymes to catalyze the transformation of diosmetin into a desired product. Diosmetin has been studied extensively for its potential use in various scientific research applications. In vivo studies have shown that diosmetin has potential anti-inflammatory, anti-tumor, and antioxidant activities. It also has potential anti-bacterial, anti-viral, and anti-fungal activities. In vitro studies have demonstrated its potential to inhibit the growth of cancer cells, as well as its ability to reduce inflammation and oxidative stress. |
| Future Directions |
There are a number of potential future directions for the use of diosmetin in scientific research. These include further exploration of its potential anti-inflammatory, anti-tumor, and antioxidant activities, as well as its potential to inhibit the growth of cancer cells. Additionally, further research is needed to better understand its mechanism of action and pharmacodynamics. Other potential future directions include exploring its potential therapeutic applications in various diseases and conditions, as well as its potential use in drug development. |
Suche 
+86 21 5895 0110 
